Datasheet

生物学的記述

Specificity	Cdk8 Antibody [G17E8] detects endogenous levels of total Cdk8 protein.
Background	CDK8 is a cyclin‑dependent kinase that functions as the catalytic core of the CDK8 kinase module within specific Mediator complexes and acts as a transcription‑regulatory kinase that integrates signaling inputs into RNA polymerase II–dependent gene expression programs. The kinase associates with cyclin C, MED12, and MED13 to form the CDK8 subcomplex, which binds the Mediator core in a reversible manner, and this configuration positions the CDK8 active site to phosphorylate components of the basal transcription machinery, transcription factors, and elongation regulators without being required for Mediator assembly itself. CDK8 phosphorylates transcription factors and coactivators, including members of the serum response and early growth response networks, and also targets the carboxy‑terminal domain of RNA polymerase II and elongation‑associated factors, which modulate the transition from initiation to productive elongation and the assembly and activity of the positive transcription elongation factor b–containing elongation complex. Within the serum response network, CDK8 acts as a positive regulator of transcriptional elongation by facilitating recruitment of P‑TEFb and BRD4 to promoters and enhancers and by preventing accumulation of hypophosphorylated, slow‑elongating RNA polymerase II complexes, which results in efficient induction of immediate‑early genes such as AP‑1 and EGR family transcription factors after mitogenic stimulation. The CDK8 kinase module also exerts context‑dependent repressive functions; Mediator complexes containing the CDK8 subcomplex can block preinitiation complex formation at some promoters and modulate the interaction between Mediator and RNA polymerase II, thereby controlling access of the basal machinery to specific transcription factor–bound regulatory regions. CDK8 activity participates in multiple signaling pathways, including Wnt/β‑catenin, TGF‑β/Smad, STAT, and nuclear hormone receptor pathways, by phosphorylating pathway‑specific transcription factors and co‑regulators and by adjusting the amplitude and duration of their transcriptional outputs, which link extracellular cues and oncogenic signaling to Mediator‑dependent gene expression. The CDK8 kinase module regulates sets of genes involved in metabolism, cell‑cycle progression, and survival, and acts as a node in life‑and‑death decisions through transcriptional control of apoptotic and autophagy genes and non‑transcriptional roles of cyclin C in mitochondrial dynamics.

Specificity

Cdk8 Antibody [G17E8] detects endogenous levels of total Cdk8 protein.

Background

CDK8 is a cyclin‑dependent kinase that functions as the catalytic core of the CDK8 kinase module within specific Mediator complexes and acts as a transcription‑regulatory kinase that integrates signaling inputs into RNA polymerase II–dependent gene expression programs. The kinase associates with cyclin C, MED12, and MED13 to form the CDK8 subcomplex, which binds the Mediator core in a reversible manner, and this configuration positions the CDK8 active site to phosphorylate components of the basal transcription machinery, transcription factors, and elongation regulators without being required for Mediator assembly itself. CDK8 phosphorylates transcription factors and coactivators, including members of the serum response and early growth response networks, and also targets the carboxy‑terminal domain of RNA polymerase II and elongation‑associated factors, which modulate the transition from initiation to productive elongation and the assembly and activity of the positive transcription elongation factor b–containing elongation complex. Within the serum response network, CDK8 acts as a positive regulator of transcriptional elongation by facilitating recruitment of P‑TEFb and BRD4 to promoters and enhancers and by preventing accumulation of hypophosphorylated, slow‑elongating RNA polymerase II complexes, which results in efficient induction of immediate‑early genes such as AP‑1 and EGR family transcription factors after mitogenic stimulation. The CDK8 kinase module also exerts context‑dependent repressive functions; Mediator complexes containing the CDK8 subcomplex can block preinitiation complex formation at some promoters and modulate the interaction between Mediator and RNA polymerase II, thereby controlling access of the basal machinery to specific transcription factor–bound regulatory regions. CDK8 activity participates in multiple signaling pathways, including Wnt/β‑catenin, TGF‑β/Smad, STAT, and nuclear hormone receptor pathways, by phosphorylating pathway‑specific transcription factors and co‑regulators and by adjusting the amplitude and duration of their transcriptional outputs, which link extracellular cues and oncogenic signaling to Mediator‑dependent gene expression. The CDK8 kinase module regulates sets of genes involved in metabolism, cell‑cycle progression, and survival, and acts as a node in life‑and‑death decisions through transcriptional control of apoptotic and autophagy genes and non‑transcriptional roles of cyclin C in mitochondrial dynamics.

使用情報

Application

WB, IP

Dilution

WB	IP
1:1000	1:30

Reactivity

Human

Source

Rabbit Monoclonal Antibody

MW

53 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

プロトコール

References

https://pubmed.ncbi.nlm.nih.gov/21327159/
https://pubmed.ncbi.nlm.nih.gov/19240132/

Cdk8 Antibody [G17E8]

生物学的記述

使用情報

References

Application Data